Nuclear imaging for immune cell tracking in vivo - Comparison of various cell labeling methods and their application

There is currently great interest in the development of cell-based therapies, particularly those focused on the idea of exploiting systemically administered immune cells for therapeutic purposes in cancer (e.g., CAR-T and CAR-NK cells). The ability to monitor the fate of cells in vivo after administration is vital for the assessment of therapeutic outcomes of immune cell-based therapies both in preclinical research and clinical practice. In this context, imaging techniques, which allow for noninvasive and real-time monitoring of the distribution and long-term viability of the adoptively transferred immune cells in the tissue of interest, are of paramount importance. Among clinically relevant in vivo imaging modalities, the nuclear imaging techniques, comprising planar scintigraphy, SPECT, and PET, are considered to be of pivotal importance to in vivo cell tracking and designing optimal treatment strategies for cell-based therapies. This review paper focuses on nuclear imaging and its role in the evaluation of immune cell-based therapies' effectiveness - tracking cells and their ability to home to the target tissue. We compare different types of radiotracers, outline various ways of immune cell labeling, and provide the latest examples for the use of nuclear imaging techniques both in preclinical studies and clinical settings. (C) 2021 The Author(s). Published by Elsevier B.V.

Automated summary

This review paper discusses the pivotal role of nuclear imaging techniques in evaluating the effectiveness of immune cell-based therapies, focusing on tracking cells and their ability to home to the target tissue. It compares different types of radiotracers, outlines various ways of immune cell labeling, and provides the latest examples for the use of nuclear imaging techniques in both preclinical studies and clinical settings.